Detalles de la búsqueda
1.
Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group.
Am J Hematol
; 92(9): E534-E541, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28612357
2.
Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine.
Ann Hematol
; 92(11): 1543-52, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23740492
3.
Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival.
Ann Hematol
; 91(12): 1887-95, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22875062
4.
Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis.
Oncotarget
; 7(21): 30492-503, 2016 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-27127180
5.
Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes.
PLoS One
; 11(10): e0164370, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27741277
Resultados
1 -
5
de 5
1
Próxima >
>>